| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
 | adenocarcinoma in situ | FANCF* | Fancf | Alliance of Genome Resources | |||
| breast carcinoma in situ | IGF2R* | Igf2r | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | TERC* | ||||||
| cervix uteri carcinoma in situ | THRB* | Thrb | Alliance of Genome Resources | ||||
| cervix uteri carcinoma in situ | IL1B* | Il1b | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | CCND2* | Ccnd2 | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | HOXB13* | Hoxb13 | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | PAK2* | Pak2 | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | RELA* | Rela | Alliance of Genome Resources | ||||
| ductal carcinoma in situ | SRC* | Src | Alliance of Genome Resources | ||||
| in situ carcinoma | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| in situ carcinoma | IGF2R* | Igf2r | Alliance of Genome Resources | ||||
| prostate carcinoma in situ | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
| prostate carcinoma in situ | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| ductal carcinoma in situ | Tg(Wap-TAg)1Depp | 1 model | |
| ductal carcinoma in situ | Tg(Wap-TAg)NP8Depp | 1 model | |